PathoQuest
Business Services · France · 51-200 Employees
View Company Info for Free
Overview
Headquarters
11 Rue Watt, Paris, Ile-de-France, 75013...Phone Number
+33 170821790Website
www.pathoquest.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About PathoQuest
PathoQuest specializes in biosafety assays utilizing next-generation sequencing (NGS) for biologics quality testing, focusing on GMP biotesting for biopharmaceuticals. Their services include adventitious virus testing, cell line characterization, and genetic analysis, catering to both global and emerging biopharma companies. With a commitment to rapid and reliable quality control, PathoQuest's NGS platform offers an ethical alternative to traditional testing methods. The company aims to transform the future of biotherapies, ensuring safety and compliance in the development of innovative therapies.Explore more
PathoQuest Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PathoQuest your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if PathoQuest is spiking on competitors!
Earning: See what the market has to say on PathoQuest recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once PathoQuest has new funding data
PathoQuest, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when PathoQuest launches new products
Check if PathoQuest has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at PathoQuest
Click to see if PathoQuest had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
PathoQuest is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PathoQuest is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PathoQuest.
PathoQuest financials insights
Gather financial insights about PathoQuest, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$5M
2019
Other Financing Round
$8.8M
PathoQuest Tech Stack
A closer look at the technologies used by PathoQuest
PathoQuest News & Media
Oxford Nanopore and PathoQuest announce the first steps in a strategic collaboration to bring the first GMP-accredited, nanopore-based biologics genetic characterisation test to market
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integration Site Analysis (ISA) test to better meet the evolving needs of the biopharmaceutical industry and the advancement of biological therapeutics. Oxford Nanopore’s technology can, with very high accuracy, read any length of native DNA, enabling the identification and comprehensive sequence assessmPathoQuest Announce the Opening of its New U.S. Facility
WAYNE, Pa. & PARIS--(BUSINESS WIRE)-- #Biologics--PathoQuest, a leader in the development and provision of Next Generation Sequencing (NGS) testing services for the biopharmaceutical industry, today announced that it has formally opened its new facility based in Wayne, PA. The 7000 sqft [650 sqm] facility has already begun to take on new clients from across North America as well as globally, allowing life-changing biologics to be tested in this key market. Jean-François Brepson, CEO of PathoQuesRiassunto: PathoQuest ottiene la certificazione NBF per i suoi servizi di controllo qualità NGS sui biofarmaci
PARIGI--(BUSINESS WIRE)--PathoQuest, organizzazione di ricerca a contratto (CRO) leader nei test di biosicurezza basati sulle tecnologie di sequenziamento genetico di nuova generazione (NGS) dei farmaci biologici, oggi ha annunciato di aver ottenuto una certificazione NBF (Norme di Buona Fabbricazione) per le attività dei test di controllo qualità effettuate presso la sua struttura di Parigi (Francia), a seguito di una recente ispezione dell'Agenzia nazionale per la sicurezza dei medicinali e dCharles River and PathoQuest Strengthen Strategic Partnership
WILMINGTON, Mass. & PARIS--(BUSINESS WIRE)--PathoQuest establishes U.S. subsidiary with state-of-the-art biologics genomic testing laboratory at Charles River’s site in Wayne, PA.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PathoQuest
Sign Up For FreeTo access detailed company insights
PathoQuest specializes in biosafety assays utilizing next-generation sequencing (NGS) for biologics quality testing, focusing on GMP biotesting for biopharmaceuticals. Their services include adventitious virus testing, cell line characterization, and genetic analysis, catering to both global and emerging biopharma companies. With a commitment to ra... Read More
